My hunch is it is to do with XV Ventilation (XV) FDA approval forward from it's clearance in Mar 2020 OR maybe a early TGA pre submission update OR maybe regulatory approval in another part of the world. However I'm a bit confused as 4dx is implementing a SaaS model rather than an actual "medical device" as such.
Unless someone can shed more light around this space.
Ann: Trading Halt, page-6
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $211.4M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 52.5¢ | 51.0¢ | $239.1K | 459.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 58828 | 51.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.0¢ | 14043 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |